Results 61 to 70 of about 15,184 (209)

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia   +3 more
wiley   +1 more source

Subclinical characteristics in HBV/HDV coinfection.

open access: yes, 2013
(A) Subclinical characteristics of the HBsAg-positive Vietnamese patients with (dark bars) and without HDV-coinfection (white bars). The serum transferase levels as well as concentration of total and direct bilirubin were significantly higher in HDV ...
Heiner Wedemeyer (32361)   +11 more
core   +1 more source

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV [PDF]

open access: yes, 2023
Background & Aims: Bulevirtide (BLV) is a small lipopeptide agent that specifically binds to the sodium taurocholate cotransporting polypeptide (NTCP) bile salt transporter and HBV/HDV receptor on the surface of human hepatocytes and inhibits HDV and
Maiorova, Evguenia   +43 more
core   +1 more source

Viral Hepatitis A, B and C in Roraima, Brazilian Amazon: Epidemiological and Serological Profile, 2012–2023

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Introduction Viral hepatitis remains a major global public health challenge, with heterogeneous epidemiological patterns across geographic and socioeconomic contexts. In the Brazilian Amazon, evidence remains limited, particularly regarding long‐term trends.
Jamilla Karla Corrêa Reis   +6 more
wiley   +1 more source

HDV-ASECU23-Most Active Countries-2022a

open access: yes, 2023
HDV-ASECU23 Top Most Active Countries ...
Bitzenis, Aristidis, Koutsoupias, Nikos
core   +1 more source

Features of clinical course of chronic hepatites of mixed viral (HBV+HCV) etiologies

open access: yesРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии, 2009
Aim of investigation. To define the leading part of viruses B and C in pathogenesis of chronic hepatitis of mixed viral etiology.Material and methods. Overall 249 patients (m 185, f 64) were investigated: 91 – with HBV and HCV markers (HBsAg+antiHCV) and
G. K. Mirodzhov   +4 more
doaj  

Analysis of a PCORnet® database identifies multi-level predictors of delta hepatitis in a U.S. hotspot

open access: yesCommunications Medicine
Background: Although New York City (NYC) is a hotspot for hepatitis delta virus (HDV) in the United States (US), the epidemiology of HDV remains poorly understood.
Lauren Alpert   +4 more
doaj   +1 more source

Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan

open access: yesKaohsiung Journal of Medical Sciences, 2016
In Taiwan, injecting drug use has been the main route of human immunodeficiency virus (HIV) transmission since 2005, with hepatitis B virus (HBV) and hepatitis D virus (HDV) also having similar transmission routes. This has now become an important public
Meng-Hsuan Hsieh   +14 more
doaj   +1 more source

Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis

open access: yesGut Pathogens, 2021
Hepatitis delta virus (HDV) is a defective single negative chain RNA virus, as its envelope protein synthesis is dependent on hepatitis B virus (HBV).
Lin-Yuan Chen   +4 more
doaj   +1 more source

ГЕПАТИТ ДЕЛЬТА: ЭТИОЛОГИЯ, КЛИНИКА, ДИАГНОСТИКА, ТЕРАПИЯ (ЛЕКЦИЯ ДЛЯ ПРАКТИЧЕСКИХ ВРАЧЕЙ)

open access: yesАрхивъ внутренней медицины, 2014
A significant part of liver disease, once considered the result of infection by hepatitis B virus (HBV), are the result of infection HBV, and hepatitis delta virus (HDV).
Т. В. Кожанова   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy